Browse by Aston Author

Refaat, A.; Pararasa, C.; Brown, Jep; Ali, A. and Griffiths, H.r. (2016). The Nrf2 activator methyl bardoxolone exacerbates mitochondrial dysfunction in palmitate-treated breast cancer cells. IN: UNSPECIFIED. .

Khanim, F.; Davies, N.; Veliça, P.; Hayden, R.; Ride, J.; Pararasa, C.; Chong, M.G.; Gunther, U.; Veerapen, N.; Winn, P.; Farmer, R.; Trivier, E.; Rigoreau, L.; Drayson, M. and Bunce, C. (2014). Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. British Journal of Cancer, 110 (6), pp. 1506-1516.

Pararasa, C.; Gao, D.; Dunston, C.R.; Bailey, C.J. and Griffiths, H.R. (2012). Palmitate induces phenotype changes in monocytes via de novo ceramide synthesis. Free Radical Biology and Medicine, 53 (Supple), S136.